The Singapore Exchange (SGX) is revising listing rules for life sciences companies, while the city-state’s central bank MAS is committing up to $111 million over three years under the renewed Financial Sector Technology and Innovation Scheme (FSTI3.0).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
